BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10950458)

  • 1. Esophageal cancer prevention, cure, and palliation.
    Burdick JS
    Semin Gastrointest Dis; 2000 Jul; 11(3):124-33. PubMed ID: 10950458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
    Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
    Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
    Reid BJ; Blount PL; Feng Z; Levine DS
    Am J Gastroenterol; 2000 Nov; 95(11):3089-96. PubMed ID: 11095322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic surveillance in Barrett's esophagus.
    Lunedei V; Bazzoli F; Pozzato P; De Luca L; Zagari RM; Fossi S; Ricciardiello L; Maltoni S; Roda E
    Minerva Gastroenterol Dietol; 2002 Jun; 48(2):63-71. PubMed ID: 16489297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
    Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques.
    May A; Gossner L; Pech O; Müller H; Vieth M; Stolte M; Ell C
    Endoscopy; 2002 Aug; 34(8):604-10. PubMed ID: 12173079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
    Thomas T; Richards CJ; de Caestecker JS; Robinson RJ
    Aliment Pharmacol Ther; 2005 Mar; 21(6):747-55. PubMed ID: 15771761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
    Weston AP; Sharma P
    Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
    Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
    Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflux disease and Barrett's esophagus.
    Haag S; Holtmann G
    Endoscopy; 2003 Feb; 35(2):112-7. PubMed ID: 12561004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.
    Pech O; May A; Günter E; Gossner L; Ell C
    Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in Barrett's esophagus: management of high grade dysplasia.
    Sharma P
    Semin Gastrointest Dis; 2001 Jan; 12(1):26-32. PubMed ID: 11215852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
    Pohl H; Sonnenberg A; Strobel S; Eckardt A; Rösch T
    Gastrointest Endosc; 2009 Oct; 70(4):623-31. PubMed ID: 19394011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.